Why it matters – Pharmaceutical Compliance, Anti-corruption and Access to Medicine
In the article, Luca Genovese and Danny Edwards, Researchers at the Access to Medicine Foundation, discuss the role of pharmaceutical companies in limiting corrupt acts and unethical behaviour to mitigate their harmful impact on access to medicine in low- and middle-income countries.